{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:00:59Z","timestamp":1770138059686,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15CA231339-0"],"award-info":[{"award-number":["1R15CA231339-0"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CPRIT RP170003"],"award-info":[{"award-number":["CPRIT RP170003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS106902"],"award-info":[{"award-number":["R01 NS106902"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA047855-04"],"award-info":[{"award-number":["R01DA047855-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS109255"],"award-info":[{"award-number":["R01NS109255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["HHSN-271-2013-00017-C"],"award-info":[{"award-number":["HHSN-271-2013-00017-C"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejmech.2023.115309","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:58:30Z","timestamp":1680062310000},"page":"115309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Studies on diketopiperazine and dipeptide analogs as opioid receptor ligands"],"prefix":"10.1016","volume":"254","author":[{"given":"Siavash","family":"Shahbazi Nia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Anwar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangchen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravan K.","family":"Jonnalagadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Ashrafur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ehsan","family":"Sifat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh","family":"Nozohouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collin","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhavalkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Hiranita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Abbruscato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Trippier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8619-9836","authenticated-orcid":false,"given":"Nadezhda A.","family":"German","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115309_bib1","series-title":"Prevalence Of Chronic Pain and High-Impact Chronic Pain Among adults\u2014United States, 2016. ; CDC","first-page":"1001","year":"2018"},{"issue":"8","key":"10.1016\/j.ejmech.2023.115309_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.ejmech.2023.115309_bib3","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2023.115309_bib4","series-title":"Pain Awareness Month \u2014 September 2018; CDC: Morbidity and Mortality Weekly Report","first-page":"1001","year":"2018"},{"issue":"9 Suppl 4","key":"10.1016\/j.ejmech.2023.115309_bib5","first-page":"S12","article-title":"Management of neuropathic pain","volume":"105","author":"Galluzzi","year":"2005","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.ejmech.2023.115309_bib6","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2147\/JPR.S127014","article-title":"The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey","volume":"10","author":"DiBonaventura","year":"2017","journal-title":"J. Pain Res."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115309_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115309_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s13365-020-00887-4","article-title":"A COVID-19 patient with intense burning pain","volume":"26","author":"Aksan","year":"2020","journal-title":"J. Neurovirol."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115309_bib9","first-page":"e575","article-title":"A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York city","volume":"96","author":"Frontera","year":"2020","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ejmech.2023.115309_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002941","article-title":"Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: a cross-sectional study","volume":"16","author":"Wei","year":"2019","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115309_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12916-018-1058-y","article-title":"Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study","volume":"16","author":"Chang","year":"2018","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115309_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41386-018-0292-5","article-title":"NIDA's medication development priorities in response to the opioid crisis: ten most wanted","volume":"44","author":"Rasmussen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2023.115309_bib13","author":"Crime"},{"key":"10.1016\/j.ejmech.2023.115309_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fphar.2014.00253","article-title":"Does the kappa opioid receptor system contribute to pain aversion?","volume":"5","author":"Cahill","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115309_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0333102417702120","article-title":"Kappa opioid receptor antagonists: a possible new class of therapeutics for migraine prevention","volume":"37","author":"Xie","year":"2017","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115309_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/j.pain.0000000000001167","article-title":"Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain","volume":"159","author":"Nation","year":"2018","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115309_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/j.pain.0000000000001458","article-title":"Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain","volume":"160","author":"Navratilova","year":"2019","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115309_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115309_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115309_bib20","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1523\/JNEUROSCI.2980-11.2012","article-title":"Stress-induced activation of the dynorphin\/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference","volume":"32","author":"Smith","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115309_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","article-title":"The kappa opioid receptor: from addiction to depression, and back","volume":"5","author":"Lalanne","year":"2014","journal-title":"Front. Psychiatr."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115309_bib22","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.celrep.2016.02.069","article-title":"Dynorphin controls the gain of an amygdalar anxiety circuit","volume":"14","author":"Crowley","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115309_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuron.2016.12.005","article-title":"Pathway- and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens neuron activity","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115309_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"13","key":"10.1016\/j.ejmech.2023.115309_bib25","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115309_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1369-1600.2012.00455.x","article-title":"The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety","volume":"17","author":"Schank","year":"2012","journal-title":"Addiction Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115309_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1369-1600.2008.00107.x","article-title":"Advances in the field of cannabinoid--opioid cross-talk","volume":"13","author":"Robledo","year":"2008","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejmech.2023.115309_bib28","series-title":"Opioids in Cancer Pain","article-title":"Opioid receptors and opioid pharmacodynamics","author":"Davis","year":"2009"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115309_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2023.115309_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.903978","article-title":"Kappa opioid receptor blockade in the amygdala mitigates pain like-behaviors by inhibiting corticotropin releasing factor neurons in a rat model of functional pain","volume":"13","author":"Yakhnitsa","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115309_bib31","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/brain\/awac153","article-title":"Chronic pain recruits hypothalamic dynorphin\/kappa opioid receptor signalling to promote wakefulness and vigilance","volume":"146","author":"Ito","year":"2023","journal-title":"Brain"},{"issue":"Pt 4","key":"10.1016\/j.ejmech.2023.115309_bib32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1099\/mic.0.27847-0","article-title":"The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis","volume":"151","author":"Gardiner","year":"2005","journal-title":"Microbiology"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115309_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/1462-2920.13080","article-title":"Gliotoxin--Bane or boon?","volume":"18","author":"Scharf","year":"2016","journal-title":"Environ. Microbiol."},{"issue":"29","key":"10.1016\/j.ejmech.2023.115309_bib34","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.1021\/ja103262m","article-title":"Transannular disulfide formation in gliotoxin biosynthesis and its role in self-resistance of the human pathogen Aspergillus fumigatus","volume":"132","author":"Scharf","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115309_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nbt1059","article-title":"A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design","volume":"23","author":"Card","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115309_bib36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/anie.201105840","article-title":"Lead-oriented synthesis: a new opportunity for synthetic chemistry","volume":"51","author":"Nadin","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"13","key":"10.1016\/j.ejmech.2023.115309_bib37","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0957-4166(03)00403-8","article-title":"Determination of the absolute stereochemistry of etzionin","volume":"14","author":"Vaz","year":"2003","journal-title":"Tetrahedron: Asymmetry"},{"issue":"47","key":"10.1016\/j.ejmech.2023.115309_bib38","doi-asserted-by":"crossref","first-page":"12822","DOI":"10.1002\/anie.201408205","article-title":"Catalytic enantioselective synthesis of atropisomeric biaryls: a cation-directed nucleophilic aromatic substitution reaction","volume":"53","author":"Armstrong","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"48","key":"10.1016\/j.ejmech.2023.115309_bib39","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1016\/j.tet.2016.05.083","article-title":"C\u2013C bond-forming reactions of ground-state aryl halides under reductive activation","volume":"72","author":"Emery","year":"2016","journal-title":"Tetrahedron"},{"issue":"15","key":"10.1016\/j.ejmech.2023.115309_bib40","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0960-894X(01)00371-7","article-title":"The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold","volume":"11","author":"Tullis","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115309_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejoc.200400558","article-title":"Total synthesis of cryptophycin 3","author":"Danner","year":"2005","journal-title":"Eur. J. Org Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2023.115309_bib42","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.tetlet.2011.01.138","article-title":"A scaleable formal total synthesis of dehydrogliotoxin","volume":"52","author":"McMahon","year":"2011","journal-title":"Tetrahedron Lett."},{"issue":"7428","key":"10.1016\/j.ejmech.2023.115309_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115309_bib44","author":"Roth"},{"issue":"38","key":"10.1016\/j.ejmech.2023.115309_bib45","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1073\/pnas.1510117112","article-title":"NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor","volume":"112","author":"O'Connor","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115309_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"issue":"15","key":"10.1016\/j.ejmech.2023.115309_bib47","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1021\/acs.jmedchem.8b00077","article-title":"Lipophilic efficiency as an important metric in drug design","volume":"61","author":"Johnson","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115309_bib48","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115309_bib49","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115309_bib50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.ejmech.2023.115309_bib51","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1002\/jps.23258","article-title":"Species difference of esterase expression and hydrolase activity in plasma","volume":"101","author":"Bahar","year":"2012","journal-title":"J. Pharmaceut. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115309_bib52","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115309_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal route of drug administration: should it Be used in experimental animal studies?","volume":"37","author":"Al Shoyaib","year":"2019","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115309_bib54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","article-title":"Peptidomimetic therapeutics: scientific approaches and opportunities","volume":"22","author":"Qvit","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.ejmech.2023.115309_bib55","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1021\/acs.jmedchem.6b01796","article-title":"Discovery of a highly potent, cell-permeable macrocyclic peptidomimetic (MM-589) targeting the WD repeat domain 5 protein (WDR5)-Mixed lineage leukemia (MLL) protein-protein interaction","volume":"60","author":"Karatas","year":"2017","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115309_bib56","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/acs.jmedchem.7b01455","article-title":"High-affinity peptidomimetic inhibitors of the DCN1-UBC12 protein-protein interaction","volume":"61","author":"Zhou","year":"2018","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115309_bib57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0306-4522(98)00251-6","article-title":"Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study","volume":"88","author":"Peckys","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2023.115309_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108456","article-title":"Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors","volume":"185","author":"Hein","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115309_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13041-020-00669-3","article-title":"Kappa opioid receptors in the central amygdala modulate spinal nociceptive processing through an action on amygdala CRF neurons","volume":"13","author":"Ji","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejmech.2023.115309_bib60","article-title":"Neuropathic pain alters reward and affect via kappa opioid receptor (KOR) upregulation","volume":"30","author":"Liu","year":"2016","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115309_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2023.115309_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109031","article-title":"Optogenetic manipulations of CeA-CRF neurons modulate pain- and anxiety-like behaviors in neuropathic pain and control rats","volume":"210","author":"Mazzitelli","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.115309_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.928587","article-title":"Sex differences in CGRP regulation and function in the amygdala in a rat model of neuropathic pain","volume":"15","author":"Presto","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.ejmech.2023.115309_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11101339","article-title":"Fear extinction-based inter-individual and sex differences in pain-related vocalizations and anxiety-like behaviors but not nocifensive reflexes","volume":"11","author":"Presto","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115309_bib65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/j.pain.0000000000001748","article-title":"Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex","volume":"161","author":"Navratilova","year":"2020","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115309_bib66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","article-title":"A fast flexible docking method using an incremental construction algorithm","volume":"261","author":"Rarey","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"23","key":"10.1016\/j.ejmech.2023.115309_bib67","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1021\/jm981037l","article-title":"FLEXS: a method for fast flexible ligand superposition","volume":"41","author":"Lemmen","year":"1998","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115309_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10822-012-9626-2","article-title":"A consistent description of HYdrogen bond and DEhydration energies in protein-ligand complexes: methods behind the HYDE scoring function","volume":"27","author":"Schneider","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2023.115309_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112866","article-title":"Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer","volume":"209","author":"Ashraf-Uz-Zaman","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2023.115309_bib70","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/cmdc.201700196","article-title":"Synthesis and antineoplastic evaluation of mitochondrial complex II (succinate dehydrogenase) inhibitors derived from atpenin A5","volume":"12","author":"Wang","year":"2017","journal-title":"ChemMedChem"},{"issue":"15","key":"10.1016\/j.ejmech.2023.115309_bib71","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","article-title":"DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment","volume":"28","author":"Volkamer","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2023.115309_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/7651_2020_311","article-title":"Estimating brain permeability using in vitro blood-brain barrier models","volume":"2367","author":"Nozohouri","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115309_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.9","article-title":"In vitro drug metabolism using liver microsomes","volume":"74","author":"Knights","year":"2016","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115309_bib74","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/jps.22792","article-title":"In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods","volume":"101","author":"Poulin","year":"2012","journal-title":"J. Pharmaceut. Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115309_bib75","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"17","key":"10.1016\/j.ejmech.2023.115309_bib76","doi-asserted-by":"crossref","first-page":"12705","DOI":"10.1021\/acs.jmedchem.1c00759","article-title":"Discovery of first-in-class peptidomimetic neurolysin activators possessing enhanced brain penetration and stability","volume":"64","author":"Rahman","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115309_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916629049","article-title":"Functional characterization of a mouse model for central post-stroke pain","volume":"12","author":"Gritsch","year":"2016","journal-title":"Mol. Pain"},{"issue":"8","key":"10.1016\/j.ejmech.2023.115309_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237451","article-title":"Blockade of the M1 muscarinic acetylcholine receptors impairs eyeblink serial feature-positive discrimination learning in mice","volume":"15","author":"Rahman","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejmech.2023.115309_bib79","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1523\/JNEUROSCI.2468-16.2016","article-title":"5-HT2C receptor knockdown in the amygdala inhibits neuropathic-pain-related plasticity and behaviors","volume":"37","author":"Ji","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115309_bib80","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2018.06.015","article-title":"Small conductance calcium activated potassium (SK) channel dependent and independent effects of riluzole on neuropathic pain-related amygdala activity and behaviors in rats","volume":"138","author":"Thompson","year":"2018","journal-title":"Neuropharmacology"},{"issue":"18","key":"10.1016\/j.ejmech.2023.115309_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184380","article-title":"Contribution of corticotropin-releasing factor receptor 1 (CRF1) to serotonin receptor 5-HT2CR function in amygdala neurons in a neuropathic pain model","volume":"20","author":"Ji","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:50:30Z","timestamp":1759330230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":81,"alternative-id":["S0223523423002751"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115309","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studies on diketopiperazine and dipeptide analogs as opioid receptor ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115309","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115309"}}